Sunday, June 19, 2022 2:05:04 PM
The COVID chase results were 'not stellar' enough to do a Phase 3 directed at the flagging COVID epidemic. NONE of the other COVID treatments were either. BP can $pread their true lies. Remdesivir, PFE-MRNA (C-19 specific) vaccines.?. AGN does not have a Dr Fakee to twist spins, only a fairly honest CSO describing 'trends' in a herd of BP$ B$.
Unconfident and opinionated claims of incompetence? GLWT in the mirror. Future or past, crystal balls or Hind sighting others. Talk to the mirror again, IMHFO....
Trading advice may be heeded. Mitigating some losses due to 'not stellar' COVID results seemed obvious as AGN sought complementary paths that may use the Data gleaned from existing work and new paths with possibilities. NO Guarantees from ANY company EVER that I have seen..
Buy-Hold-Sell.
...GLTA...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM